Author Archives: Molly S. McGlaughlin

CMO Fusion: Where Stainless Steel Meets Disposable Technology

by and

Molly McGlaughlin, director of strategy and business development, BioVectra  Jim Stout, director of process science, BioVectra   McGlaughlin introduced BioVectra. The company has been in business for 45 years and is based in Canada. Its a well-established contract development and manufacturing organization (CDMO) and fine-chemical manufacturer, and is a subsidiary of Mallinckrodt Pharmaceuticals. BioVectra started out as diagnostic reagent company and now has a complementary set of niche capabilities. From 10 years of fermentation experience, it was a logical progression to…

August 21, 2018

An Emerging Answer to the Downstream Bottleneck

by

    Biotechnology companies have invested billions of US dollars in new manufacturing infrastructure, expanding the industry’s total mammalian cell culture production capacity from 670,000 L in 2002 to 2,550,000 L in 2010 (Figure 1) (1). This capacity expansion is estimated to have cost the industry about $20 billion (Figure 2) (1). Figure 1: Macroporous structure of Natrix chromatography media (see ()   Figure 1: ()   Figure 2: ()   That production capacity (and the investment it represents) is…

May 1, 2012